Application of a Novel Allergen-Specific Immune Signature Directed Approach to Dietary Elimination Therapy in Patients With Eosinophilic Esophagitis (IDiET)

NCT02722148 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Eosinophilic Esophagitis

Interventions

DEVICE: Novel Allergen-Specific Immune Signature Directed Approach to Dietary Elimination Therapy

Sponsor

University of North Carolina, Chapel Hill

Collaborators

[object Object]